(DGA Core) The Stanford Diabetes Genomics and Analysis (DGA) Core is designed to support the genomic research of Stanford Diabetes Research Center (SDRC) investigators through access to next-generation sequencing and modern bioinformatics analysis. Nucleotide sequencing has become essential for formulating and resolving crucial biological questions in many contexts, like diabetes. This includes determining the underlying causes of human diseases to monitoring gene expression, elucidating regulatory networks and exploring organismal diversity that may impact human health, like human microbiomes. Thus, high-throughput sequencers have become a transformative tool for a wide variety of studies in both pure and applied biomedical science. Researchers use this technology increasingly for an ever-broadening range of applications to detect and characterize nucleic acid molecules (RNA and DNA). The overall goal of the Stanford DGA Core is to provide SDRC investigators with a next-generation sequencing facility composed of state-of-the-art laboratory, computational facilities and informatics support. The DGA Core is committed to providing SDRC laboratories with the expertise and technical support necessary to realize the potential of next-generation sequencing in a cost-effective matter regardless of their existing expertise in genomics. The Stanford DGA Core will offer a complete package of services ranging from study design consultation, library preparation services, access to sequencing technologies, and analysis and interpretation of sequencing data. SDRC laboratories can leverage the technologies and expertise of the Stanford DGA Core to overcome cost-prohibitive barriers of entry into genomics which include technologically advanced facilities and equipment, and computational infrastructure that can only be achieved in a center setting like the Stanford DGA Core. Based on the strengths of the Stanford DGA Core and its contributions, the specific aims of the DGA Core are to provide SDR core users guidance with design of their next-generation sequencing projects, access to a broad range of nucleotide library preparation services, access to sequencing services with modern sequencing technologies, and support with data analysis and interpretation of their sequencing projects The proven strengths of the Stanford DGA Core in these techniques will provide investigators with a unique opportunity to effectively apply powerful research approaches that would be prohibitively difficult for individual laboratories to develop. The Stanford DGA Core will serve as an invaluable resource for the SDRC, providing investigators with the next-generation sequencing expertise and training necessary to examine the genome at a level that is limited to a relatively few laboratories. This Core is committed to serving SDRC investigators in their experiments, from start to finish.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
1P30DK116074-01
Application #
9442593
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
1
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Singh, Madhurima; Bittner, Stefanie; Li, Yihang et al. (2018) Anti-hyperlipidaemic effects of synthetic analogues of nordihydroguaiaretic acid in dyslipidaemic rats. Br J Pharmacol :
DeSalvo, Daniel J; Miller, Kellee M; Hermann, Julia M et al. (2018) Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative. Pediatr Diabetes 19:1271-1275
Poon, Anna K; Meyer, Michelle L; Reaven, Gerald et al. (2018) Short-Term Repeatability of Insulin Resistance Indexes in Older Adults: The Atherosclerosis Risk in Communities Study. J Clin Endocrinol Metab 103:2175-2181
Ingelsson, Erik; McCarthy, Mark I (2018) Human Genetics of Obesity and Type 2 Diabetes Mellitus: Past, Present, and Future. Circ Genom Precis Med 11:e002090
Peiris, Heshan; Park, Sangbin; Louis, Shreya et al. (2018) Discovering human diabetes-risk gene function with genetics and physiological assays. Nat Commun 9:3855
Singh, Amar Bahadur; Dong, Bin; Kraemer, Fredric B et al. (2018) Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice. Arterioscler Thromb Vasc Biol 38:2448-2459
Chan, Jackie K W; Bittner, Stefanie; Bittner, Alex et al. (2018) Nordihydroguaiaretic Acid, a Lignan from Larrea tridentata (Creosote Bush), Protects Against American Lifestyle-Induced Obesity Syndrome Diet-Induced Metabolic Dysfunction in Mice. J Pharmacol Exp Ther 365:281-290
Zanetti, Daniela; Tikkanen, Emmi; Gustafsson, Stefan et al. (2018) Birthweight, Type 2 Diabetes Mellitus, and Cardiovascular Disease: Addressing the Barker Hypothesis With Mendelian Randomization. Circ Genom Precis Med 11:e002054
Horton, Timothy M; Allegretti, Paul A; Lee, Sooyeon et al. (2018) Zinc-Chelating Small Molecules Preferentially Accumulate and Function within Pancreatic ? Cells. Cell Chem Biol :
Mayer-Davis, Elizabeth J; Maahs, David M; Seid, Michael et al. (2018) Efficacy of the Flexible Lifestyles Empowering Change intervention on metabolic and psychosocial outcomes in adolescents with type 1 diabetes (FLEX): a randomised controlled trial. Lancet Child Adolesc Health 2:635-646

Showing the most recent 10 out of 46 publications